Adenosine A_2A receptor deficiency prevents p38MAPK activation and apoptosis of mouse hippocampal cells in the chronic hypoxic-hypercapnia model

References

• Rosenberg SR, Kalhan R, Mannino DM. Epidemiology of chronic obstructive pulmonary disease: prevalence, morbidity, mortality, and risk factors. Semin Respir Crit Care Med. 2015 Aug;36(4):457–469.
   PubMed Web of Science ®Google Scholar
• Shield KD, Rehm J. Global risk factor rankings: the importance of age-based health loss inequities caused by alcohol and other risk factors. BMC Res Notes. 2015 Jun;9(8):231.
   Google Scholar
• Cleutjens FA, Janssen DJ, Ponds RW, et al. COgnitive-pulmonary disease. Biomed Res Int. 2014;2014:697825.
   PubMedGoogle Scholar
• Singh B, Parsaik AK, Mielke MM, et al. Chronic obstructive pulmonary disease and association with mild cognitive impairment: the Mayo Clinic Study of Aging. Mayo Clin Proc. 2013 Nov;88(11):1222–1230.
   PubMed Web of Science ®Google Scholar
• Min JJ, Huo XL, Xiang LY, et al. Protective effect of Dl-3n-butylphthalide on learning and memory impairment induced by chronic intermittent hypoxia-hypercapnia exposure. Sci Rep. 2014 Jul 3;4:5555.
   PubMed Web of Science ®Google Scholar
• Klein M, Gauggel S, Sachs G, et al. Impact of chronic obstructive pulmonary disease (COPD) on attention functions. Respir Med. 2010 Jan;104(1):52–60.
   PubMed Web of Science ®Google Scholar
• Stuss DT, Peterkin I, Guzman DA, et al. Chronic obstructive pulmonary disease: effects of hypoxia on neurological and neuropsychological measures. J Clin Exp Neuropsychol. 1997 Aug;19(4):515–524.
   PubMed Web of Science ®Google Scholar
• Zheng GQ, Wang Y, Wang XT. Chronic hypoxia-hypercapnia influences cognitive function: a possible new model of cognitive dysfunction in chronic obstructive pulmonary disease. Med Hypotheses. 2008;71(1):111–113.
   PubMed Web of Science ®Google Scholar
• Lin YY, Chen KY, Huo XL, et al. Cholinergic dysfunctions are correlated with memory deficits in rats exposed to chronic hypoxia-hypercapnia. Chinese J of Neurology. 2013;46:47–50.
   Google Scholar
• Shao SM, Chen SF, Yong LI, et al. Effect of chronic hypoxic hypercapnia on the expression of Bcl-2 and Bax genes and apoptosis in rat hippocampal cells. J Wenzhou Med Col. 2008:1:12–14.
   Google Scholar
• Venton B, Nguyen ME, Ross A. Mechanism and function of transient adenosine release in the brain.  Purinergic Signalling. 2014;10:661–664.
   Google Scholar
• Dulla CG, Masino SA. Physiologic and metabolic regulation of adenosine: mechanisms. New York: Springer New York; 2013. ( (S. Masino, Boison D, editors. Adenosine: A Key Link between Metabolism and Brain Activity)).
   Google Scholar
• Saransaari P, Oja SS. Involvement of nitric oxide in adenosine release in the developing and adult mouse hippocampus. Neurochem Res. 2004 Jan;29(1):219–225.
   PubMed Web of Science ®Google Scholar
• Dos Santos-Rodrigues A, Pereira MR, Brito R, et al. Adenosine transporters and receptors: key elements for retinal function and neuroprotection. Vitam Horm. 2015;98:487–523.
   PubMed Web of Science ®Google Scholar
• Haller S, Montandon ML, Rodriguez C, et al. Acute caffeine administration effect on brain activation patterns in mild cognitive impairment. J Alzheimers Dis. 2014;41(1):101–112.
   PubMed Web of Science ®Google Scholar
• Simoes AP, Duarte JA, Agasse F, et al. Blockade of adenosine A2A receptors prevents interleukin-1beta-induced exacerbation of neuronal toxicity through a p38 mitogen-activated protein kinase pathway. J Neuroinflammation. 2012 Aug 20;9:204.
   PubMed Web of Science ®Google Scholar
• Li W, Dai S, An J, et al. Genetic inactivation of adenosine A2A receptors attenuates acute traumatic brain injury in the mouse cortical impact model. Exp Neurol. 2009 Jan;215(1):69–76.
   PubMed Web of Science ®Google Scholar
• Chen PZ, He WJ, Zhu ZR, et al. Adenosine A2A receptor involves in neuroinflammation-mediated cognitive decline through activating microglia under acute hypobaric hypoxia. Behav Brain Res. 2018 Jul 16;347:99–107.
   PubMed Web of Science ®Google Scholar
• Chen JF, Chern Y. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies. Handb Exp Pharmacol. 2011;200:267–310.
   PubMedGoogle Scholar
• Mehta A, Prabhakar, Prabhakar M, et al. Excitotoxicity: bridge to various triggers in neurodegenerative;disorders. Eur J Pharmacol. 2013;698(1–3):6–18.
   PubMed Web of Science ®Google Scholar
• Stone DK, Reynolds AD, Mosley RL, et al. Innate and adaptive immunity for the pathobiology of Parkinson’s disease. Antioxid Redox Signal. 2009 Sep;11(9):2151–2166.
   PubMed Web of Science ®Google Scholar
• Ansoleaga B, Jove M, Schluter A, et al. Deregulation of purine metabolism in Alzheimer’s disease. Neurobiol Aging. 2015 Jan;36(1):68–80.
   PubMed Web of Science ®Google Scholar
• Blum D, Martire A, Burnouf S, et al. Adenosine Receptors in Huntington’s Disease. New York: Springer New York; 2013. (S. Masino, Boison D, editors. Adenosine: A Key Link between Metabolism and Brain Activity).
   Google Scholar
• Lopes LV, Sebastiao AM, Ribeiro JA. Adenosine and related drugs in brain diseases: present and future in clinical trials. Curr Top Med Chem. 2011;11(8):1087–1101.
   PubMed Web of Science ®Google Scholar
• Chen JF, Huang Z, Ma J, et al. A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci. 1999 Nov 1;19(21):9192–9200.
   PubMed Web of Science ®Google Scholar
• Yu L, Huang Z, Mariani J, et al. Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury. Nat Med. 2004 Oct;10(10):1081–1087.
   PubMed Web of Science ®Google Scholar
• Srivaratharajah K, Cui A, McAneney J, et al. Chronic hypoxic hypercapnia modifies in vivo and in vitro ventilatory chemoreflexes in the cane toad. Respir Physiol Neurobiol. 2008 Feb 29;160(3):249–258.
   PubMed Web of Science ®Google Scholar
• Chalah A, Khosravi-Far R. The mitochondrial death pathway. Adv Exp Med Biol. 2008;615:25–45.
   PubMed Web of Science ®Google Scholar
• Calissano P, Matrone C, Amadoro G. Apoptosis and in vitro Alzheimer disease neuronal models. Commun Integr Biol. 2009;2(2):163–169.
   PubMedGoogle Scholar
• Melah KE, Lu SY-F, Hoscheidt SM, et al. Cerebrospinal fluid markers of alzheimer’s disease pathology and microglial activation are associated with altered white matter microstructure in asymptomatic adults at risk for alzheimer’s disease. J Alzheimers Dis. 2016;50(3):873–886.
   PubMed Web of Science ®Google Scholar
• Silva CG, Porciuncula LO, Canas PM, et al. Blockade of adenosine A(2A) receptors prevents staurosporine-induced apoptosis of rat hippocampal neurons. Neurobiol Dis. 2007 Aug;27(2):182–189.
   PubMed Web of Science ®Google Scholar
• Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001 Mar 1;410(6824):37–40.
   PubMed Web of Science ®Google Scholar
• Schulte G, Fredholm BB. Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signal. 2003 Sep;15(9):813–827.
   PubMed Web of Science ®Google Scholar
• Kapfhamer D, Taylor S, Zou ME, et al. Taok2 controls behavioral response to ethanol in mice. Genes Brain Behav. 2013 Feb;12(1):87–97.
   PubMed Web of Science ®Google Scholar
• Bachstetter AD, Xing B, Almeida LD, et al. Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Aβ). J Neuroinflammation. 2011;8(1):79.
   PubMedGoogle Scholar
• Owens TW, Valentijn AJ, J-P U, et al. Apoptosis commitment and activation of mitochondrial Bax during anoikis is regulated by p38MAPK. Cell Death Differ. 2009;16(11):1551–1562.
   PubMed Web of Science ®Google Scholar
• Melani A, Gianfriddo M, Vannucchi MG, et al.The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia. Brain Res. 2006 Feb 16; 1073–1074:470–480.
   PubMed Web of Science ®Google Scholar